By Ana Sandoiu Fact checked by Jasmin Collier As the homeopathic industry grows, the Food and Drug Administration (FDA) issue a statement to present two major steps they are taking to protect the public from the potentially harmful effects of products labeled as “homeopathic.” According to some estimates, a third of adults and more than...
Post
Chronic Itch: New Therapy, Complexities
“End of the antihistamine era” as new strategies target neural mechanisms by Charles Bankhead, Senior Editor, MedPage TodayOctober 18, 2019 LAS VEGAS — More options than ever exist for atopic itch conditions, offering the potential for better control but also increasing the complexity of patient management, a long-time itch research and clinician said here. “The most important thing to know, and you have...
Post
HUMM Releases First Affordable Patch for Improving Working Memory: Exclusive Interview
OCTOBER 18TH, 2019 ALICE FERNGEXCLUSIVE, NEUROLOGY, PSYCHIATRY, SPORTS MEDICINE We previously interviewed Humm, a San Francisco-based neuroscience company, when they had first released their Edge headset – an electrical stimulation device that helped users by boosting their working memory. Humm is focused on helping people continue to learn and grow throughout their lives. The idea behind their innovations is that through stimulation of...
Post
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
By ANDREW JOSEPH @Drew Q Joseph Vertex Pharmaceuticals on Monday won approval for its fourth treatment for cystic fibrosis, a combination drug that extends a new form of therapy to 90% of CF patients. The drug will be marketed as Trikafta. The list price is $311,000 per year — the same as one of Vertex’s (VRTX) earlier CF treatments....
Post
One in three pain patients suffer side effects after ketamine infusion therapy
by American Society of Anesthesiologists As the opioid epidemic continues to devastate the United States, ketamine use has grown as a pain management alternative, yet more than one in three patients may experience side effects such as hallucinations and visual disturbances, suggests new research presented at the Anesthesiology 2019 annual meeting. Ketamine is a powerful...
Post
Topical wound oxygen therapy helps heal diabetic foot ulcers
(HealthDay)—Adjuvant cyclical pressure topical wound oxygen (TWO2) therapy, compared with sham control therapy, in addition to optimal standard of care is superior for healing chronic diabetic foot ulcers (DFUs), according to a study published online Oct. 16 in Diabetes Care. Robert G. Frykberg, M.D., from Diabetic Foot Consultants at Midwestern University in Glendale, Arizona, and...
Post
Drug combination reverses hypersensitivity to noise in a model of autism spectrum disorder
by Anne Trafton, Massachusetts Institute of Technology People with autism often experience hypersensitivity to noise and other sensory input. MIT neuroscientists have now identified two brain circuits that help tune out distracting sensory information, and they have found a way to reverse noise hypersensitivity in mice by boosting the activity of those circuits. One of the circuits the researchers identified is involved in filtering noise, while the...
Post
ResMed Releases World’s First Tube-Down Nasal Cradle CPAP Mask
OCTOBER 21ST, 2019 MEDGADGET EDITORS CARDIOLOGY, MEDICINE ResMed is releasing a new nasal cradle CPAP mask that features a front-facing tube that points downward. The AirFit N30 mask is the first of its kind, as similar masks typically have the air tube connect on top of the head, which makes them uncomfortable for many patients. The AirFit N30 is also ResMed’s lightest CPAP mask, and the company has been trying to minimize...
Post
Competitor accuses 23andMe of ‘false negatives’ in cancer-gene testing
By SHARON BEGLEY when 23andMe received government permission in 2017 to sell health-related genetic testing, it came with several conditions, including that the company tell customers that its brand of testing can miss disease-causing variants. Now, in a study presented on Thursday at the annual meeting of the American Society of Human Genetics, a competitor has analyzed the likelihood of such...
Post
Scientists find solution to Gulf War Illness in FDA-approved antiviral drugs
by University of South Carolina A recent study led by scientists at the University of South Carolina’s Arnold School of Public Health has shown that adjusting GI tract viruses by repurposing existing FDA-approved antiviral drugs offers a route for effective treatment for Gulf War Illness and its myriad of symptoms. Their findings were published in...